PRPO logo.png
Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time
May 10, 2021 10:30 ET | Precipio, Inc.
NEW HAVEN, Conn., May 10, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched a new, four-hour Acute Myeloid Leukemia (AML)...
22157.jpg
Leukapheresis Market by Product, Leukopak, Indication, Application, End-user - Global Forecast to 2026
April 14, 2021 07:33 ET | Research and Markets
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Leukapheresis Market by Product (Devices, Filters, Columns, Disposables), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple...
22157.jpg
Global Acute Myeloid Leukemia (AML) Disease Analysis Report 2021: On Average, it Takes 10.8 Years from Phase I to Approval, Compared to 9.6 Years in the Overall Oncology Space
April 12, 2021 06:48 ET | Research and Markets
Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Acute Myeloid Leukemia (AML)" report has been added to ResearchAndMarkets.com's offering. AML is a type of heterogeneous...
22157.jpg
Outlook on the Chronic Myeloid Leukemia (CML) Treatment Global Market to 2029 - by Treatment Type and Geography
March 30, 2021 07:48 ET | Research and Markets
Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "Chronic Myeloid Leukemia (CML) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
Retired Cancer Doctor, Edward Arenson MD CWSP, Chronicles Inspiring 50-Year Career in Compelling New Memoir
January 25, 2021 06:15 ET | XlibrisUS
DENVER, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Now at the end of his rich medical career, Edward Arenson MD CWSP, is sharing the touching and candid stories of his brave young patients as well as paying...
PRPO logo.png
Precipio Signs HemeScreen™ Deals with Two Leading Oncology Groups
January 20, 2021 10:00 ET | Precipio, Inc.
NEW HAVEN, Conn., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has signed agreements with two of the largest oncology practices in the US,...
22157.jpg
$135 Billion Immuno-Oncology Markets, 2024
January 07, 2021 08:13 ET | Research and Markets
Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Market, by Type (mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)), by Application (Lung,...
22157.jpg
Global Hematology and Coagulation Testing Markets Report 2020 with Discussion of COVID-19
October 28, 2020 06:53 ET | Research and Markets
Dublin, Oct. 28, 2020 (GLOBE NEWSWIRE) -- The "Hematology and Coagulation Markets (Lab-based and Decentralized Markets)" report has been added to ResearchAndMarkets.com's offering. Hematology and...
Aptose Biosciences Inc. logo
Aptose Initiates Dosing of CG-806 in Patients with Acute Myeloid Leukemia
October 19, 2020 07:00 ET | Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated...
Witness a father’s love for his son in ‘Life Marrow’
October 01, 2020 00:07 ET | Balboa Press AU
SYDNEY, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Destin Writer shares the story of his two-year-old son who was diagnosed with leukemia in 2017 and the challenges he faced as a father in his memoir “Life...